logo
#

Latest news with #marketdecline

ABN Amro Analysts See ESG Bond Issuance Dropping ‘Considerably'
ABN Amro Analysts See ESG Bond Issuance Dropping ‘Considerably'

Bloomberg

time5 days ago

  • Business
  • Bloomberg

ABN Amro Analysts See ESG Bond Issuance Dropping ‘Considerably'

Issuance of euro-denominated ESG bonds is likely to see a pronounced decline in 2025, as negative sentiment fanned by political backlash weighs on the market, according to analysts at ABN Amro NV. ESG issuance is 'expected to considerably lag in 2025,' amid 'a noticeable surge in negative news related to ESG in the first half of the year,' analysts Marta Ferro Teixeira and Filipa de Carvalho Tomás wrote in a note on Friday.

Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know
Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know

Yahoo

time11-07-2025

  • Business
  • Yahoo

Guardant Health, Gilead Sciences, Inspire Medical Systems, Enovis, and AMN Healthcare Services Stocks Trade Down, What You Need To Know

A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. The wider market sentiment turned negative after the White House announced plans to impose a 35% tariff on Canadian imports, sparking renewed fears of a trade war. This news prompted a sell-off across major U.S. indexes, including the S&P 500 and the Dow Jones Industrial Average, as investors grew concerned about the potential economic impact of escalating protectionist policies. The healthcare sector is especially vulnerable to such tensions due to its deeply integrated supply chains with Canada for pharmaceuticals and medical devices, meaning increased costs and potential disruptions. Additionally, ongoing U.S. policy headwinds aimed at lowering drug prices and specific corporate challenges, like those faced by UnitedHealth Group, further compounded the sector's decline. As a result, the Health Care SPDR ETF (XLV) fell 1.0%, underperforming even as major indices pared some losses. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Testing & Diagnostics Services company Guardant Health (NASDAQ:GH) fell 3.2%. Is now the time to buy Guardant Health? Access our full analysis report here, it's free. Therapeutics company Gilead Sciences (NASDAQ:GILD) fell 3.7%. Is now the time to buy Gilead Sciences? Access our full analysis report here, it's free. Medical Devices & Supplies - Specialty company Inspire Medical Systems (NYSE:INSP) fell 4.7%. Is now the time to buy Inspire Medical Systems? Access our full analysis report here, it's free. Medical Devices & Supplies - Specialty company Enovis (NYSE:ENOV) fell 4.9%. Is now the time to buy Enovis? Access our full analysis report here, it's free. Specialized Medical & Nursing Services company AMN Healthcare Services (NYSE:AMN) fell 3.2%. Is now the time to buy AMN Healthcare Services? Access our full analysis report here, it's free. Enovis's shares are quite volatile and have had 18 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Enovis is down 22.9% since the beginning of the year, and at $34.15 per share, it is trading 30.8% below its 52-week high of $49.33 from December 2024. Investors who bought $1,000 worth of Enovis's shares 5 years ago would now be looking at an investment worth $401.24. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story. Sign in to access your portfolio

Alcohol Stocks Tumble As Health And Cannabis Trends Surge
Alcohol Stocks Tumble As Health And Cannabis Trends Surge

Forbes

time08-07-2025

  • Business
  • Forbes

Alcohol Stocks Tumble As Health And Cannabis Trends Surge

Beer, wine and spirit sales are down as consumers recognize growing health concerns of consuming ... More alcohol. (Photo by) Alcohol has been a part of society for thousands of years, but even the oldest industries are not immune to disruption. Demand for beer, wine and spirits has ebbed and flowed with changing tastes, economic cycles and cultural. Today, the alcohol industry is going through another soft patch, and the decline in the stock prices of major alcohol producers indicates the current slump in sales may be more than temporary. Diversified conglomerates such as Diageo and Constellation Brands have seen their share prices drop meaningfully over the last several years. Diageo, maker of Guinness beer, Johnny Walker whisky, Don Julio tequila and Smirnoff vodka, has seen its stock price fall nearly 50% from its high at the end of 2021. The stock price of Constellation Brands, owner of Corona beer and Mondavi wines, has collapsed 33.5% over the last year. Brown-Forman, the 155-year-old company that makes Jack Daniel's whisky, is coping with a decline in sales and gross margins, as well as a 58% plunge in its total return over the last three years. Alcohol stocks have lagged the S&P 500 over the last three years. What is behind the global drop in demand? It's a combination of several factors, some of which are structural and others more cyclical. Generational changes in behavior, health and wellness concerns, economic pressures, and the rise of alternative recreational drugs are just a few of the trends impacting alcohol sales. Understanding each of these trends — and whether they will accelerate or moderate — is crucial to determining whether the decline in alcohol stocks represents a value trap or an opportunity to purchase brand-leading companies at discounted valuations. Trends Impacting Decline In Alcohol Sales A December 2024 NCSolutions consumer sentiment survey found that nearly one in two Americans are trying to drink less alcohol in 2025, a 44% rise since 2023. This trend is led by Gen Z (ages 13-28), where 65% of those surveyed plan to reduce alcohol intake and 39% intend to adopt a dry lifestyle. Social media platforms are filled with content promoting health and wellness, including the benefits of reducing or abstaining from alcohol. Some of these influencers are former addicts touting the dangers of alcohol abuse, while others, such as Andrew Huberman, approach the topic from a scientific and medical perspective. Social media, and the fact that everybody has a camera on their phone, also creates fear of public shaming or having embarrassing moments go viral, deterring some Gen Z individuals from drinking. With many colleges and employers routinely checking the social media accounts of applicants, nobody wants these types of moments etched in history. The U.S. Surgeon General's January 2025 report on alcohol and cancer risk was a warning to both consumers and producers. The report found that even one drink daily raises the risk of developing seven types of cancer. The Surgeon General recommends that cancer warning labels be placed on alcoholic beverages to increase public awareness of these risks, similar to what is done in South Korea. Public awareness of the health risks of alcohol is growing. Gallup's Consumption Habits 2024 poll shows a new high of 45% of Americans say drinking one or two alcoholic beverages per day is bad for one's health. This marks a six-percentage-point increase since last year and a 17-point increase since the prior reading in 2018. Cost-of-living pressures have also led to a decline in overall alcohol consumption. Consumers are going out less and are reluctant to spend up to $25 for a cocktail at higher-end bars and restaurants. "What has occurred is that occasions on which beer is consumed have decreased," said Constellation Brands CEO Bill Newlands in a call to investors following the release of Q1 FY 2026 results. However, Newlands noted that people are still spending the same amount of money on alcohol when they do go out. Lifestyle trends like weight-loss medications and cannabis use are also putting a dent in alcohol sales. JP Morgan estimates there will be 30 million GLP-1 users in the U.S by 2030, or approximately 9% of the population. Obesity drugs such as Ozempic have been proven to reduce the desire for alcohol. With the growing availability and legalization of cannabis, marijuana is becoming an alternative to drinking, particularly in younger generations. A December 2024 survey conducted by Bloomberg Intelligence found that approximately 74% of young adults aged 18-24 report using cannabis at least once a week as a substitute for alcohol. Many consumers view cannabis as a safer, healthier, and more controlled experience than alcohol, without the consequences of a hangover. The threat to the alcohol industry is even more acute given the rise in popularity of THC-infused drinks. Fortune Business Insights projects the THC beverage market will grow from USD 3 billion in 2024 to USD 117 billion by 2032. THC-infused drinks provide a opportunity for cannabis companies to capture share of the beverage market. Brown-Forman warned that the business is seeing pressure from cannabis, weight-loss drugs and lower demand from Generation Z. "We've been saying that for 1.5 years now. And I know on the sell-side that the world seems to be a little bit split on the extent of the pressure that it's putting on our category. We'd be naive if we didn't say that there isn't some pressure coming from those," said CEO Lawson Whiting in an earnings call in June. Alcohol Industry Reaction To Downtrend Global alcohol volumes shrank by -1% in 2024, according to IWSR, which specializes in data, analytics and insights for the alcohol industry. Volumes fell by -3% in the U.S. and by -5% in China. Despite the negative trends in many countries, several emerging markets offer growth prospects. "Amid continuing challenges for beverage alcohol around the world, India is spearheading a new era of developing market expansion, with Brazil, Mexico, South Africa and Türkiye all poised for strong gains over the next decade," said Emily Neill is COO of Research & Operations at IWSR in a press release announcing its global growth forecast in alcohol sales. With developed markets stagnating, many beverage companies have adopted premiumization models by upscaling their offerings to attract consumers who are choosing to drink less but are seeking higher-quality products. At the same time, firms are diversifying into non-alcoholic alternatives to capture the growing sober-curious market. At least some savvy investors are betting on an industry recovery, including Warren Buffett. Berkshire Hathaway has increased its total stake in Constellation Brands, now owning 6.6% of the company. Constellation Brands' relatively attractive 13.3 times forward price-to-earnings ratio, combined with its top-tier beer brands, makes it a classic contrarian-value play for Berkshire. The big worry for investors is that the decline in alcohol consumption is a generational reset and not just a temporary dip. Like tobacco before it, alcohol is being re-evaluated through the lens of health, culture, and social relevance. The companies that adapt and innovate in this new environment, not those that try to rekindle old habits, will be the ones that succeed.

Top Stock Movers Now: Tesla, Shell, Uber, and More
Top Stock Movers Now: Tesla, Shell, Uber, and More

Yahoo

time07-07-2025

  • Business
  • Yahoo

Top Stock Movers Now: Tesla, Shell, Uber, and More

U.S. equities declined at midday as the market waited for new tariff announcements from the White House. Tesla shares dropped as CEO Elon Musk announced he was starting a new political party, and continued to feud with President Trump. Wells Fargo raised the price target on Uber Technologies, pointing to the rideshare giant's growth potential and market expansion.U.S. equities fell at midday as the market awaited word from the Trump administration about new tariffs. The Dow Jones Industrial Average, S&P 500, and Nasdaq all declined. Tesla (TSLA) was the worst-performing stock in the S&P 500 as CEO Elon Musk jumped back into the political fray, announcing a new political party and continuing to spar with President Trump on social media. U.S.-listed shares of Shell (SHEL) slid after the energy giant warned its current-quarter natural gas trading and optimization would be "significantly lower" than the first quarter. Tyson Foods (TSN) shares dipped when Piper Sandler lowered its full-year earnings estimate, pointing to continuing issues with beef demand. Uber Technologies (UBER) shares gained when Wells Fargo raised the price target on prospects for growth and market expansion for the biggest rideshare company. Shares of WNS (Holdings) Ltd. (WNS) jumped when French IT services provider Capgemini said it would acquire the business process management firm for $3.3 billion. Wynn Resorts (WYNN) shares climbed when Goldman Sachs initiated coverage of the casino operator with a "buy" rating. Oil futures rose. Gold prices fell. The yield on the 10-year Treasury note was up. The U.S. dollar advanced on the euro, pound, and yen. Trading in major cryptocurrencies was mostly lower. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Counterpoint: Global smartwatch market continues to decline in Q1 2025
Counterpoint: Global smartwatch market continues to decline in Q1 2025

GSM Arena

time04-07-2025

  • Business
  • GSM Arena

Counterpoint: Global smartwatch market continues to decline in Q1 2025

It's not looking great for the smartwatch industry as analysts from Counterpoint have recorded a fifth consecutive quarter of decline with 2% year-on-year slip. However, China is experiencing a surge in smartwatch shipments, with a whopping 37% year-on-year growth. Experts point out two major reasons for the global smartwatch market decline. The first is the waning of Apple smartwatch sales, accompanied by a significant and persistent deceleration in India's once-booming smartwatch market. Still, Apple retains the top spot with 20% global share, while recording 9% decline in shipments. Apple is followed by Huawei, which grew 53%, and so did Xiaomi, from 6% last year to 10%, recording the same 53% growth as Huawei. Samsung lost nearly 23% of its market share year-over-year, dropping from 9% to 7% of the global share. Consumer preferences are seeing notable changes as people are looking for more expensive and feature-rich devices. The $100-$200 segment experienced a 21% growth, while the sub-$100 category saw a 17% decline in shipments. Looking ahead, Counterpoint believes that the smartwatch market will see a modest uptick in sales by the end of 2025, with around 3% growth. Source

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store